{"id":9140,"date":"2024-06-27T14:49:28","date_gmt":"2024-06-27T12:49:28","guid":{"rendered":"https:\/\/www.dms-imaging.com\/?page_id=9140"},"modified":"2026-04-14T17:54:20","modified_gmt":"2026-04-14T15:54:20","slug":"communiques-de-presse","status":"publish","type":"page","link":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/","title":{"rendered":"Communiqu\u00e9s de presse"},"content":{"rendered":"<p>[vc_row][vc_column][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][ld_fancy_heading tag=\u00a0\u00bbh2&Prime; alignment=\u00a0\u00bbtext-left\u00a0\u00bb]Communiqu\u00e9s de presse[\/ld_fancy_heading][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_accordion size=\u00a0\u00bbmd\u00a0\u00bb borders=\u00a0\u00bbaccordion-title-bordered\u00a0\u00bb items_shadow=\u00a0\u00bbyes\u00a0\u00bb heading_shadow=\u00a0\u00bbyes\u00a0\u00bb show_icon=\u00a0\u00bbyes\u00a0\u00bb i_add_icon=\u00a0\u00bbtrue\u00a0\u00bb expander_size=\u00a0\u00bbaccordion-expander-lg\u00a0\u00bb i_type=\u00a0\u00bblinea\u00a0\u00bb active_add_icon=\u00a0\u00bbtrue\u00a0\u00bb active_type=\u00a0\u00bblinea\u00a0\u00bb use_custom_fonts_title=\u00a0\u00bbtrue\u00a0\u00bb i_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-add\u00a0\u00bb active_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-remove\u00a0\u00bb fs=\u00a0\u00bb18px\u00a0\u00bb border_color=\u00a0\u00bbrgb(240, 242, 250)\u00a0\u00bb exp_color=\u00a0\u00bbrgb(0, 109, 255)\u00a0\u00bb bottom_margin=\u00a0\u00bb15px\u00a0\u00bb heading_color=\u00a0\u00bbrgb(0, 35, 82)\u00a0\u00bb fw=\u00a0\u00bb600&Prime; active_bg_color=\u00a0\u00bbrgb(0, 77, 182)\u00a0\u00bb active_exp_color=\u00a0\u00bbrgb(255, 255, 255)\u00a0\u00bb][vc_accordion_tab title=\u00a0\u00bb2026&Prime; tab_id=\u00a0\u00bbld-1573557703923-2b536dc1-8433&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/04\/DMS-GROUP-CP-2026.04.14-RESULTATS-ANNUELS-2025-FR.pdf\" target=\"_blank\" rel=\"noopener\">14\/04\/2026 &#8211; Nouvelle forte progression des r\u00e9sultats annuels sur l\u2019exercice 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/04\/DMS-GROUP-CP-2026.04.13-Visioconference-FR.pdf\" target=\"_blank\" rel=\"noopener\">13\/04\/2026 &#8211; Visioconf\u00e9rence DMS Group destin\u00e9e aux actionnaires et investisseurs individuels<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/04\/DMS-GROUP-CP-2026.04.07-MDR-FR.pdf\" target=\"_blank\" rel=\"noopener\">07\/04\/2026 &#8211; DMS Group obtient la certification europ\u00e9enne MDR pour sa gamme d\u2019ost\u00e9odensitom\u00e8tres STRATOS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/03\/DMS-GROUP-CP-2026.03.27-Financement-BEI-FR.pdf\" target=\"_blank\" rel=\"noopener\">27\/03\/2026 &#8211; La Banque Europ\u00e9enne d\u2019Investissement accorde \u00e0 DMS Group une ligne de financement allant jusqu\u2019\u00e0 20 m\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/01\/DMS-GROUP-CP-2026.01.19-CA-FY-2025.pdf\" target=\"_blank\" rel=\"noopener\">19\/01\/2026 &#8211; 50,0 M\u20ac de Chiffre d\u2019Affaires annuel 2025, en croissance organique de +9%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2026\/02\/DMS-GROUP-CP-2026.01.06-Bilan-semestriel-contrat-de-liquidite-FR.pdf\" target=\"_blank\" rel=\"noopener\">06\/01\/2026 &#8211; Bilan semestriel du contrat de liquidit\u00e9 au 31 d\u00e9cembre 2025<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2025&Prime; tab_id=\u00a0\u00bblqd-1767718114970-e7a333d1-fdd2&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/11\/CP_2025_11_04_DMS-GROUP-CP-Homologation-JPI-Healthcare-04112025-FR-1.pdf\" target=\"_blank\" rel=\"noopener\">04\/11\/2025 &#8211; DMS Group obtient l&rsquo;homologation de la FDA pour le mobile de radiologie !M1 dans le cadre de son partenariat avec JPI Healthcare Solutions aux \u00c9tats-Unis<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/10\/CP_2025.10.20_DMS-GROUP-CA-T3-2025-VDEF.pdf\" target=\"_blank\" rel=\"noopener\">20\/10\/2025 &#8211; Acc\u00e9l\u00e9ration de la croissance au 3\u00e8me trimestre 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/09\/CP_2025_09_29_DMS-GROUP-Resultats-S1-2025-VDEF_FR.pdf\" target=\"_blank\" rel=\"noopener\">29\/09\/2025 &#8211; Progression soutenue des r\u00e9sultats semestriels 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/09\/CP_2025_09_25_DMS-Group_Webinaire-actionnaires-individuels_30092025.pdf\" target=\"_blank\" rel=\"noopener\">25\/09\/2025 &#8211; Visioconf\u00e9rence DMS Group destin\u00e9e aux actionnaires et investisseurs individuels<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/09\/CP_2025_09_01_Visite-site.pdf\" target=\"_blank\" rel=\"noopener\">01\/09\/2025 &#8211; DMS Group ouvre ses portes \u00e0 ses actionnaires et ses partenaires financiers le 12 septembre 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/08\/FR_CP_2025_08_27_DMS-GROUP_DMS-GROUP_AUGMENTATIONCPTL.pdf\">27\/08\/2025 &#8211; DMS Group annonce le succ\u00e8s de son augmentation de capital avec suppression du droit pr\u00e9f\u00e9rentiel de souscription<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/08\/FR_CP_2025_08_18_DMS-GROUP_INX-decision-INX-BPI-NXSTG.pdf\">18\/08\/2025 &#8211; Une Alliance Internationale pour une Souverainet\u00e9 Technologique Europ\u00e9enne en Imagerie M\u00e9dicale \/ Augmentation de Capital d\u2019un Montant Global de 6,9 Millions d\u2019Euros R\u00e9serv\u00e9e \u00e0 Innolux, Innocare, Bpifrance et NextStage AM<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/07\/CP_2025_07_21_DMS-GROUP-CA-S1-2025_FR.pdf\" target=\"_blank\" rel=\"noopener\">21\/07\/2025 &#8211; Nouvelle hausse du Chiffre d\u2019Affaires : +3 % au 1er semestre 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/07\/CP_2025_07_07_DMS-GROUP_accord-innolux.pdf\" target=\"_blank\" rel=\"noopener\">07\/07\/2025 &#8211; DMS Group, Innolux et Innocare annoncent un accord de principe en vue d\u2019un partenariat strat\u00e9gique dans l\u2019imagerie m\u00e9dicale<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/06\/CP_2025_06_17_DMS-GROUP_Gouvernance.pdf\" target=\"_blank\" rel=\"noopener\">17\/06\/2025 &#8211; Renforcement de la structure de gouvernance de DMS Group : nomination de Julien Delpech en tant qu\u2019administrateur ind\u00e9pendant<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/06\/CP_2025_06_12_DMS-GROUP_ODDO.pdf\" target=\"_blank\" rel=\"noopener\">12\/06\/2025 &#8211; DMS Group : initiation de couverture du titre par ODDO BHF<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/05\/CP_2025_05_12_DMS-GROUP_Homologation_commercialisation_M1.pdf\" target=\"_blank\" rel=\"noopener\">12\/05\/2025 &#8211; DMS Group : homologation FDA pour le !M1 et commercialisation imm\u00e9diate aux Etats-Unis avec Medlink<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/05\/CP_2025.05.07_DMS-GROUP_NATIXIS_ODDO_BHF.pdf\" target=\"_blank\" rel=\"noopener\">07\/05\/2025 &#8211; DMS Group : mise en oeuvre d\u2019un contrat de liquidit\u00e9 avec Natixis ODDO BHF<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/04\/CP_2025_04_22_DMS-GROUP-CA-T1-2025.pdf\" target=\"_blank\" rel=\"noopener\">22\/04\/2025 &#8211; Chiffre d\u2019affaires du 1er trimestre 2025 : DMS Group enregistre une progression \u00e0 deux chiffres de son chiffre d&rsquo;affaires<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/04\/CP_2025_04_14_DMS-Group_resultats_annuels_2024.pdf\" target=\"_blank\" rel=\"noopener\">14\/04\/2025 &#8211; R\u00e9sultats Annuels 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/04\/CP_2025_04_22_DMS-GROUP-organise-une-visioconference.pdf\" target=\"_blank\" rel=\"noopener\">11\/04\/2025 &#8211; Organisation d\u2019une visioconf\u00e9rence destin\u00e9e aux actionnaires et investisseurs individuels<br \/>\n<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/03\/CP_2025_03_07_DMS-GROUP-Urgence-Ukraine_FR.pdf\" target=\"_blank\" rel=\"noopener\">07\/03\/2025 &#8211; Le Groupe DMS, s\u00e9lectionn\u00e9 par les autorit\u00e9s ukrainiennes pour la livraison de 120 mobiles de radiologie d\u2019urgence, pour un contrat de 11 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/02\/CP_2025_01_25_DMS-GROUP_ECR_2025_FR.pdf\" target=\"_blank\" rel=\"noopener\">25\/02\/2025 &#8211; DMS Group pr\u00e9sente ses innovations majeures au Congr\u00e8s Europ\u00e9en de Radiologie (ECR) 2025<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/01\/CP_2025_01_20_DMS-Group-BSA.pdf\" target=\"_blank\" rel=\"noopener\">20\/01\/2025 &#8211; Termes et conditions des bons de souscription d&rsquo;actions allou\u00e9s dans le cadre de l\u2019acquisition de Solutions For Tomorrow (SFT)<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/01\/CP_16_01_2025_FR_DMS-GROUP-CA-2024.pdf\" target=\"_blank\" rel=\"noopener\">16\/01\/2025 &#8211; DMS Group : une nouvelle ann\u00e9e de croissance dynamique<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/01\/CP_2025_01_14_DMS-GROUP-organise-une-visioconference.pdf\" target=\"_blank\" rel=\"noopener\">14\/01\/2025 \u2013 Organisation d\u2019une visioconf\u00e9rence destin\u00e9e aux actionnaires et investisseurs individuels<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2025\/01\/CP_2025_01_08_DMS-GROUP-organise-une-visioconference.pdf\" target=\"_blank\" rel=\"noopener\">08\/01\/2025 \u2013 Organisation d\u2019une visioconf\u00e9rence destin\u00e9e aux actionnaires et investisseurs individuels<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2024&Prime; tab_id=\u00a0\u00bblqd-1736330744310-3b28d99d-4e6c\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/12\/CP_20_12_2024_DMS-GROUP_UK_-Verso-Capital-Increases-Its-Stake-in-DMS-Group.pdf\" target=\"_blank\" rel=\"noopener\">20\/12\/2024 \u2013 [EN] Verso Capital increases its Stake in DMS Group<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/12\/CP_20_12_2024_DMS-GROUP-Augmentation-participation-Verso-Capital.pdf\" target=\"_blank\" rel=\"noopener\">20\/12\/2024 \u2013 [FR] Verso capital augmente sa participation dans DMS Group<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/10\/2024-10-17_DMS-GROUP-CA-T3-2024.pdf\" target=\"_blank\" rel=\"noopener\">17\/10\/2024 \u2013 CHIFFRE D\u2019AFFAIRES DU 3\u00c8ME TRIMESTRE 2024 : DMS GROUP POURSUIT SA CROISSANCE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/10\/2024-10-08_DMS-GROUP-organise-une-visioconference.pdf\" target=\"_blank\" rel=\"noopener\">08\/10\/2024 \u2013 Organisation d\u2019une visioconf\u00e9rence destin\u00e9e aux actionnaires et investisseurs individuels<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/10\/2024-10-07_DMS-GROUP-Resultats-1er-semestre-2024.pdf\" target=\"_blank\" rel=\"noopener\">07\/10\/2024 \u2013 UN PREMIER SEMESTRE 2024 SOUS LE SIGNE DE LA CROISSANCE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/10\/2024-10-02_DMS-GROUP-lance-ses-innovations-aux-Journees-Francophones-de-Radiologie-JFR-2024.pdf\" target=\"_blank\" rel=\"noopener\">02\/10\/2024 \u2013 DMS Group lance ses innovations aux Journ\u00e9es Francophones de Radiologie (JFR) 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/09\/2024-09-03_Signature-Partenariat-JPI-1.pdf\" target=\"_blank\" rel=\"noopener\">03\/09\/2024 \u2013 DMS Group annonce la signature d\u2019un partenariat strat\u00e9gique avec JPI Healthcare Solutions pour la vente de mobiles de radiologie M1 sur le march\u00e9 am\u00e9ricain et \u00e0 l\u2019international<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/09\/2024-07-18_DMS-Group_CA-S1-2024_Vdef.pdf\" target=\"_blank\" rel=\"noopener\">18\/07\/2024 \u2013 Chiffre d\u2019affaires du 1er semestre 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/09\/DMS-CP-20240711-FR.pdf\" target=\"_blank\" rel=\"noopener\">11\/07\/2024 \u2013 VISIOCONFERENCE \u2013 Le mercredi 24 juillet \u00e0 9h30<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/09\/2024-06-11_Partenariat-Medlink-Imaging_EN.pdf\" target=\"_blank\" rel=\"noopener\">11\/06\/2024 \u2013 [EN] DMS Group Announces Strategic Agreement with Medlink Imaging for the Sale of M1 Radiology Solutions in the United States<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-06-11_Partenariat-Medlink-Imaging_FR.pdf\" target=\"_blank\" rel=\"noopener\">11\/06\/2024 \u2013 [FR] DMS GROUP ANNONCE LA SIGNATURE D\u2019UN ACCORD STRAT\u00c9GIQUE AVEC MEDLINK IMAGING POUR LA VENTE DES SOLUTIONS DE RADIOLOGIE M1 AUX \u00c9TATS-UNIS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-05-28_DMS-Group_Notation-ESG_Vdef.pdf\" target=\"_blank\" rel=\"noopener\">28\/05\/2024 \u2013 1RE NOTATION ESG DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-05-27_Communique-de-mise-a-disposition-des-documents-dassemblee-generale-V3.pdf\" target=\"_blank\" rel=\"noopener\">27\/05\/2024 \u2013 MISE \u00c0 DISPOSITION DES DOCUMENTS PR\u00c9PARATOIRES \u00c0 L\u2019ASSEMBLE G\u00c9N\u00c9RALE MIXTE DU 17 JUIN 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-05-15_DMS-Group_Accord-cadre-Danemark.pdf\" target=\"_blank\" rel=\"noopener\">15\/05\/2024 \u2013 SOLUTIONS FOR TOMORROW, FILIALE DU GROUPE DMS, ET SANTAX MEDICO REMPORTENT L\u2019ACCORD-CADRE POUR LA LIVRAISON DE MOBILES DE RADIOLOGIE AU DANEMARK<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-04-18_DMS-Group_Resultats-2023-et-CA-T1-2024.pdf\" target=\"_blank\" rel=\"noopener\">18\/04\/2024 \u2013 R\u00c9SULTATS ANNUELS 2023 \/ CHIFFRE D\u2019AFFAIRES DU 1ER TRIMESTRE 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-02-02_DMS-Group_Cyberattaque.pdf\" target=\"_blank\" rel=\"noopener\">02\/02\/2024 \u2013 INTERCEPTION D\u2019UNE CYBERATTAQUE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-01-22_DMS-Group-CP-Retail-Day.pdf\" target=\"_blank\" rel=\"noopener\">22\/01\/2024 \u2013 DMS GROUP ANNONCE SA PARTICIPATION \u00c0 LA PREMI\u00c8RE \u00c9DITION DU RETAIL DAY LE 7 F\u00c9VRIER 2024<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-01-18_DMS-Group_CA-T4-2023.pdf\" target=\"_blank\" rel=\"noopener\">18\/01\/2024 \u2013 CHIFFRE D\u2019AFFAIRES ANNUEL 2023 : +20% \u00c0 42,2 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2024-01-16_DMS-Group-accompagne-la-delegation-francaise-au-Forum-de-Davos.pdf\" target=\"_blank\" rel=\"noopener\">16\/01\/2024 \u2013 DMS GROUP INVIT\u00c9 PAR L\u2019ELYS\u00c9E \u00c0 DAVOS POUR ACCOMPAGNER LE PR\u00c9SIDENT EMMANUEL MACRON<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2023&Prime; tab_id=\u00a0\u00bbld-1573557848857-fe47078b-be98&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-12-04_DMS-Group-presente-ses-nouvelles-solutions.pdf\" target=\"_blank\" rel=\"noopener\">04\/12\/2023 \u2013 DMS GROUP PR\u00c9SENTE SES NOUVELLES SOLUTIONS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-10-19_DMS-Group_CA-T3-2023.pdf\" target=\"_blank\" rel=\"noopener\">19\/10\/2023 \u2013 CHIFFRE D\u2019AFFAIRES DU 3E TRIMESTRE 2023 : +22% \u00c0 8,9 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-10-17_DMS-Group_MAJ-du-calendrier-financier-2023.pdf\" target=\"_blank\" rel=\"noopener\">17\/10\/2023- MISE \u00c0 JOUR DU CALENDRIER FINANCIER 2023<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-10-12_dms-group_visioconference-actionnaires-individuels-19-10-2023.pdf\" target=\"_blank\" rel=\"noopener\">12\/10\/2023 -VISIOCONF\u00c9RENCE ACTIONNAIRES PARTICULIERS LE JEUDI 19 OCTOBRE 2023 \u00c0 18H. CHIFFRE D\u2019AFFAIRES DU 3\u00c8ME TRIMESTRE 2023 ET PERSPECTIVES.<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-10-03_DMS-Group_Acquisition-de-SFT_FR-1.pdf\" target=\"_blank\" rel=\"noopener\">03\/10\/2023 \u2013 FINALISATION DE L\u2019ACQUISITION DE SOLUTIONS FOR TOMORROW (SFT)<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-09-21_DMS-Group_Resultats-S1-2023.pdf\" target=\"_blank\" rel=\"noopener\">21\/09\/2023 \u2013 R\u00c9SULTATS DU 1ER SEMESTRE 2023 : CROISSANCE SOUTENUE ET AM\u00c9LIORATION DE LA RENTABILIT\u00c9 OP\u00c9RATIONNELLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-09-13_DMS-Group_MAJ-du-calendrier-financier-2023.pdf\" target=\"_blank\" rel=\"noopener\">13\/09\/2023 \u2013 MISE \u00c0 JOUR DU CALENDRIER FINANCIER 2023<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-09-13_DMS-Group_Visioconference-actionnaires-individuels-21-09-2023.pdf\" target=\"_blank\" rel=\"noopener\">13\/09\/2023 \u2013 VISIOCONFERENCE ACTIONNAIRES PARTICULIERS LE JEUDI 21 SEPTEMBRE 2023<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.07.26.DMSGroupacquisitionSFTfinalFR.pdf\" target=\"_blank\" rel=\"noopener\">26\/07\/2023 \u2013 ACCORD D\u2019ACQUISITION DE SOLUTIONS FOR TOMORROW (SFT)<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-07-20_DMS-Group_CA-S1-2023_def.pdf\" target=\"_blank\" rel=\"noopener\">20\/07\/2023 \u2013 CHIFFRE D\u2019AFFAIRES DU 1ER SEMESTRE 2023 : +14% \u00c0 20,8 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-07-11_DMS-Group_Visioconference-actionnaires-individuels.pdf\" target=\"_blank\" rel=\"noopener\">11\/07\/2023 \u2013 VISIOCONF\u00c9RENCE ACTIONNAIRES-PARTICULIERS LE JEUDI 20 JUILLET 2023 \u00c0 18H<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-06-07_DMS-Group_BSA-actionnaires_Vdef.pdf\" target=\"_blank\" rel=\"noopener\">07\/06\/2023 \u2013 ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D\u2019ACTIONS AU B\u00c9N\u00c9FICE DE TOUS LES ACTIONNAIRES DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-05-30_DMS-Group_Initiation-de-couverture.pdf\" target=\"_blank\" rel=\"noopener\">30\/05\/2023 \u2013 INITIATION DE COUVERTURE DE DMS GROUP PAR EUROLAND CORPORATE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023-05-23_DMS-Group_Arret-de-la-cour-dappel-de-Liege_FR.pdf\" target=\"_blank\" rel=\"noopener\">23\/05\/2023 \u2013 ARR\u00caT DE LA PROC\u00c9DURE EN COURS AVEC THIERRY LEGON ET R\u00c9TABLISSEMENT DU PLAN DE R\u00c9ORGANISATION JUDICIAIRE DE DMS IMAGING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.05.22-Communique-de-mise-a-disposition-des-documents-dassemblee-generale.pdf\" target=\"_blank\" rel=\"noopener\">22\/05\/2023 \u2013 MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L\u2019AG MIXTE DU 12 JUIN 2023<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.05.16.DMS-Group_Visioconference-actionnaires-individuels-V1.pdf\" target=\"_blank\" rel=\"noopener\">16\/05\/2023 \u2013 VISIOCONF\u00c9RENCE ACTIONNAIRES ET INVESTISSEURS PARTICULIERS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.04.28.DMS-Group_CP_RA-2022_28042023_FR.pdf\" target=\"_blank\" rel=\"noopener\">27\/04\/2023 \u2013 R\u00c9SULTATS ANNUELS 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.04.20.DMS-Imaging_CP_CA-2022_20042023_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/04\/2023 \u2013 CHIFFRE D\u2019AFFAIRES TRIMESTRIEL RECORD<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.02.08.DMS-Group_CP_08022023_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">08\/02\/2023 \u2013 ACQUISITION PAR DMS GROUP DE L\u2019INT\u00c9GRALIT\u00c9 DE LA PARTICIPATION DE LA FAMILLE ANSEL REPR\u00c9SENTANT 12,89% DU CAPITAL<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.01.20.DMS-Imaging_CP_CA-2022_20012023_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/01\/2023 \u2013 CHIFFRE D\u2019AFFAIRES 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.01.12.DMS-Imaging_CP_Contrat-Fujifilm-Healthcaree_FR_12012023.pdf\" target=\"_blank\" rel=\"noopener\">12\/01\/2023 \u2013 FUJIFILM HEALTHCARE ITALIE REMPORTE UN APPEL D\u2019OFFRES POUR 96 TABLES DE RADIOLOGIE CON\u00c7UES ET PRODUITES PAR DMS IMAGING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2023.01.04.DMS-Imaging_CP_Ambitions-2023_04012023_FR.pdf\" target=\"_blank\" rel=\"noopener\">04\/01\/2023 \u2013 DMS GROUP D\u00c9VOILE SES AMBITIONS POUR L\u2019EXERCICE 2023<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2022&Prime; tab_id=\u00a0\u00bbld-1573557855085-a110d9e8-dd5b\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.11.30.DMS_CP_Canon-RSNA_30112022_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">30\/11\/2022 \u2013 DMS GROUP ANNONCE UN PARTENARIAT AVEC CANON MEDICAL SYSTEMS EUROPE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.10.25.DMS_CP_Plan-strategique_25102022_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">25\/10\/2022 \u2013 DMS GROUP D\u00c9VOILE SES NOUVELLES AMBITIONS ET PR\u00c9SENTE SON PLAN STRAT\u00c9GIQUE : \u00ab IMAGING 2027 \u00bb\u00a0<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.10.21.DMS-Group-CP-Protocole-Hybrigenics-21102022.pdf\" target=\"_blank\" rel=\"noopener\">21\/10\/2022 \u2013 SIGNATURE D\u2019UN PROTOCOLE D\u2019ACCORD EN VUE D\u2019ORGANISER LA CESSION DU BLOC DE TITRES D\u00c9TENUS PAR DMS GROUP DANS HYBRIGENICS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.10.20.DMS_CP_CA-T3-2022_20102022_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/10\/2022 \u2013 CHIFFRE D\u2019AFFAIRES \u00c0 NEUF MOIS DE 25,9 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.09.30.DMS_CP_RS-2022_30092022_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2022 \u2013 R\u00c9SULTATS SEMESTRIELS 2022 : 4,6% DE MARGE D\u2019EBITDA DONT 10,3% POUR LA DIVISION DMS IMAGING \/\/ PR\u00c9SENTATION DU FUTUR PLAN STRAT\u00c9GIQUE AU MOIS D\u2019OCTOBRE 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.09.14.DMS_MOT-PRESIDENT_14092022_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">14\/09\/2022 \u2013 MESSAGE DU PR\u00c9SIDENT \u2013 DIRECTEUR G\u00c9N\u00c9RAL DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.09.13DMS_CP_GOUVERNANCE-DMS-IMAGING_13092022_FR.pdf\" target=\"_blank\" rel=\"noopener\">13\/09\/2022 \u2013 EVOLUTION DE LA GOUVERNANCE DE DMS IMAGING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.07.20.DMS_CP_CA-S1-2022_20072022_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/07\/2022 \u2013 CHIFFRE D\u2019AFFAIRES EN CROISSANCE DE +4% AU 2\u00c8ME TRIMESTRE 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.07.18.DMS_CP_Evolution-Gouvernance_18072022_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">18\/07\/2022 \u2013 EVOLUTION DE LA GOUVERNANCE : MISE EN PLACE D\u2019UN NOUVEAU CONSEIL D\u2019ADMINISTRATION ET NOMINATION DE SAMUEL SANCERNI EN TANT QUE PR\u00c9SIDENT \u2013 DIRECTEUR G\u00c9N\u00c9RAL DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.04.29_DMS_CP_RA-2021_29042022_FR-1.pdf\" target=\"_blank\" rel=\"noopener\">29\/04\/2022 \u2013 R\u00c9SULTATS ANNUELS 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.04.20_DMS_CP_CA-T1-2022_20042022_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">20\/04\/2022 \u2013 CHIFFRE D\u2019AFFAIRES DE 8,9 M\u20ac AU 1ER TRIMESTRE 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.03.01_DMS_CP_Transfert-Euronext-Growth_29022022.pdf\" target=\"_blank\" rel=\"noopener\">01\/03\/2022 \u2013 TRANSFERT DE LA COTATION DES TITRES DE LA SOCI\u00c9T\u00c9 DMS GROUP SUR LE MARCH\u00c9 EURONEXT GROWTH EFFECTIF LE 3 MARS 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.01.25.DMS_CP_Closing-ASIT-Biotech_25012022_FR.pdf\" target=\"_blank\" rel=\"noopener\">25\/01\/2022 \u2013 FINALISATION DE L\u2019OP\u00c9RATION D\u2019APPORT DE LA DIVISION IMAGERIE M\u00c9DICALE DU GROUPE DMS \u00c0 ASIT BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.01.20_DMS_CP_CA-2021_20012022_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/01\/2022 \u2013 PROGRESSION DYNAMIQUE DE 16% DE L\u2019ACTIVIT\u00c9 EN 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2022.01.12_DMS_CP_CESSION-WELLNESS-12012022_FR.pdf\" target=\"_blank\" rel=\"noopener\">12\/01\/2022 \u2013 CESSION DE LA DIVISION DMS WELLNESS<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2021&Prime; tab_id=\u00a0\u00bbld-1573557971281-cb873053-3190&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.12.20_DMS_CP_AGM-SECONDE-CONVOCATION-30122021.pdf\" target=\"_blank\" rel=\"noopener\">20\/12\/2021 \u2013 AVIS DE DEUXI\u00c8ME CONVOCATION \u00c0 L\u2019ASSEMBL\u00c9E G\u00c9N\u00c9RALE MIXTE DU 30 D\u00c9CEMBRE 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.11.26_Communique-de-mise-a-disposition-des-documents-dassemblee-generale.pdf\" target=\"_blank\" rel=\"noopener\">26\/11\/2021 \u2013 MISE \u00c0 DISPOSITION DES DOCUMENTS PR\u00c9PARATOIRES \u00c0 L\u2019ASSEMBLE G\u00c9N\u00c9RALE MIXTE DU 17 D\u00c9CEMBRE 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.11.12_DMS_CP_Projet-transfert-Euronext-Growth_12112021_FR.pdf\" target=\"_blank\" rel=\"noopener\">12\/11\/2021 \u2013 REPRISE DU PROJET DE TRANSFERT DE LA COTATION DES TITRES DMS GROUP SUR LE MARCH\u00c9 EURONEXT GROWTH \u00c0 PARIS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.11.08_DMS_CP_08112021.pdf\" target=\"_blank\" rel=\"noopener\">08\/11\/2021 \u2013 SIGNATURE D\u2019UN AVENANT AU TRAIT\u00c9 D\u2019APPORT RELATIF \u00c0 L\u2019APPORT DE LA DIVISION IMAGERIE M\u00c9DICALE DU GROUPE DMS \u00c0 ASIT BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.10.20_DMS_CP_CA-T3.pdf\" target=\"_blank\" rel=\"noopener\">20\/10\/2021 \u2013 CROISSANCE SOUTENUE AU 3\u00c8ME TRIMESTRE 2021 : +25%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.09.30_DMS_CP_RS-2021_30092021_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2021 \u2013 R\u00c9SULTATS SEMESTRIELS 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.09.15_DMS_CP_15092021_FR.pdf\" target=\"_blank\" rel=\"noopener\">15\/09\/2021 \u2013 LA COUR D\u2019APPEL CONFIRME LA D\u00c9CISION DU TRIBUNAL DE L\u2019ENTREPRISE DE LI\u00c8GE PERMETTANT AINSI AU PLAN DE R\u00c9ORGANISATION D\u2019ASIT BIOTECH DE SE POURSUIVRE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.07.21_DMS_CP_CA-S1-2021_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">21\/07\/2021 \u2013 CROISSANCE ORGANIQUE SOUTENUE AU 1ER SEMESTRE 2021 : +17%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.04.30_DMS_CP_RA-2020_FR.pdf\" target=\"_blank\" rel=\"noopener\">30\/04\/2021 \u2013 R\u00c9SULTATS ANNUELS 2020<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.04.21_DMS_CP_CA-T1-2021_FR.pdf\" target=\"_blank\" rel=\"noopener\">21\/04\/2021 \u2013 CROISSANCE DYNAMIQUE DE +18% AU 1ER TRIMESTRE 2021<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.04.16_DMS_CP_Signature-traite-ASIT.pdf\" target=\"_blank\" rel=\"noopener\">16\/04\/2021 \u2013 SIGNATURE DU TRAIT\u00c9 D\u2019APPORT LIANT RELATIF \u00c0 L\u2019APPORT DE LA DIVISION IMAGERIE M\u00c9DICALE DE DMS GROUP \u00c0 ASIT BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.04.13_DMS_CP_LAA_FR.pdf\" target=\"_blank\" rel=\"noopener\">13\/04\/2021 \u2013 LETTRE DU PR\u00c9SIDENT DE DMS GROUP AUX ACTIONNAIRES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.04.08_DMS_CP_Reprise-negociations-ASIT-Biotech_FR.pdf\" target=\"_blank\" rel=\"noopener\">08\/04\/2021 \u2013 REPRISE DES N\u00c9GOCIATIONS ENTRE ASIT BIOTECH ET DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.03.16_DMS_CP_Fin-discussions-ASIT-Biotech_FR.pdf\" target=\"_blank\" rel=\"noopener\">16\/03\/2021 \u2013 FIN DES DISCUSSIONS AVEC ASIT BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.02.04_DMS_CP_FUJUFILM-HOMOLOGATION-FDA-US_FR.pdf\" target=\"_blank\" rel=\"noopener\">04\/02\/2021 \u2013 HOMOLOGATION DE LA FDA POUR LA TABLE DE RADIOLOGIE PLATINUM ADAM : EXTENSION SUR LE MARCH\u00c9 AM\u00c9RICAIN DE L\u2019ACCORD COMMERCIAL AVEC FUJIFILM<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.01.20_DMS_CP_CA-2020_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/01\/2021 \u2013 CHIFFRE D\u2019AFFAIRES ANNUEL 2020 DE 32,1 M\u20ac EN CROISSANCE DE +4%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2021.01.11_DMS_CP_PARTENARIAT-ASIT_FR.pdf\" target=\"_blank\" rel=\"noopener\">11\/01\/2021 \u2013 DMS GROUP ANNONCE UN PR\u00c9ACCORD DE PARTENARIAT AVEC ASIT BIOTECH<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2020&Prime; tab_id=\u00a0\u00bbld-1573557979674-b9d6884a-b21e\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.12.21_DMS_CP_SDRA-COVID-INSERM.pdf\" target=\"_blank\" rel=\"noopener\">21\/12\/2020 \u2013 SIGNATURE D\u2019UN NOUVEAU CONTRAT DE COLLABORATION DE RECHERCHE ENTRE L\u2019INSERM ET DMS BIOTECH SUR LE TRAITEMENT DU SYNDROME DE D\u00c9TRESSE RESPIRATOIRE AIGU\u00cb (SDRA)<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.12.16_DMS_CP_AG-2-28122020.pdf\" target=\"_blank\" rel=\"noopener\">16\/12\/2020 \u2013 ASSEMBL\u00c9E G\u00c9N\u00c9RALE MIXTE DES ACTIONNAIRES LE 28 D\u00c9CEMBRE 2020 SUR 2NDE CONVOCATION<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.11.03_DMS_CP_Projet-transfert-Euronext-Growth.pdf\" target=\"_blank\" rel=\"noopener\">03\/11\/2020 \u2013 PROJET DE TRANSFERT DE LA COTATION DES TITRES DMS GROUP SUR LE MARCH\u00c9 EURONEXT GROWTH \u00c0 PARIS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.10.20_DMS_CP_CA-T3-2020_FR-VF.pdf\" target=\"_blank\" rel=\"noopener\">20\/10\/2020 \u2013 DMS GROUP GARDE LE CAP DE LA CROISSANCE AU 3\u00c8ME TRIMESTRE : +9%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.10.02_DMS-CP_DMS-BIOTECH.pdf\" target=\"_blank\" rel=\"noopener\">02\/10\/2020 \u2013 DMS BIOTECH PARTICIPE \u00c0 L\u2019EFFORT COLLECTIF CONTRE LE CORONAVIRUS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.09.30_DMS_CP_RS-2020_FR.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2020 \u2013 PROGRESSION DES R\u00c9SULTATS SEMESTRIELS 2020<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.09.22_DMS_CP_DMS-BIOTECH-Partenariat-HongKong.pdf\" target=\"_blank\" rel=\"noopener\">22\/09\/2020 \u2013 DMS BIOTECH SE D\u00c9VELOPPE \u00c0 HONG KONG AVEC SON PARTENAIRE WKK INTERNATIONAL LIMITED<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.08.03_DMS_CP_Arthrose_FR.pdf\" target=\"_blank\" rel=\"noopener\">03\/08\/2020 \u2013 POINT D\u2019AVANCEMENT SUR L\u2019ESSAI CLINIQUE SUR L\u2019ARTHROSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.07.20_DMS_CP_CA-T2-2020_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/07\/2020 \u2013 SOLIDE PROGRESSION DE +7% DE L\u2019ACTIVIT\u00c9 AU 2\u00c8ME TRIMESTRE 2020 DANS LE CONTEXTE DE PAND\u00c9MIE DE CORONAVIRUS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.05.29_DMS_CP_FIN-CONTRAT-OBLIGATIONS-REMBOURSABLES_FR.pdf\" target=\"_blank\" rel=\"noopener\">29\/05\/2020 \u2013 DMS GROUP MET FIN AU CONTRAT DE FINANCEMENT PAR BONS D\u2019\u00c9MISSION D\u2019OBLIGATIONS REMBOURSABLES EN NUM\u00c9RAIRE ET\/OU EN ACTIONS DMS OU HYBRIGENICS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.05.06_DMS_CP_DMSBiotech-Hybrigenics_FR.pdf\" target=\"_blank\" rel=\"noopener\">06\/05\/2020 \u2013 MISE EN \u0152UVRE D\u2019UN PARTENARIAT AVEC SGH HEALTHCARING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.04.30_DMS_CP_RA-2019_FR.pdf\" target=\"_blank\" rel=\"noopener\">30\/04\/2020 \u2013 R\u00c9SULTATS ANNUELS 2019<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.04.20_DMS_CP_CA-T1-2020_20042020_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/04\/2020 \u2013 CROISSANCE DE +16% AU 1ER TRIMESTRE 2020 \u2013 POINT DE SITUATION COVID-19<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.03.04_DMS_CP_Emission-OC_FR.pdf\" target=\"_blank\" rel=\"noopener\">04\/03\/2020 \u2013 LEV\u00c9E DE FONDS DE 3 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.03.02_DMS-CP_DMS-BIOTECH-Etude-Arthrose.pdf\" target=\"_blank\" rel=\"noopener\">02\/03\/2020 \u2013 FINALISATION DE L\u2019\u00c9TUDE RELATIVE \u00c0 L\u2019ESSAI CLINIQUE PILOTE SUR L\u2019UTILISATION DES CELLULES DU TISSU ADIPEUX DANS LE TRAITEMENT DE L\u2019ARTHROSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2020.01.15_DMS_CP_CA-2019_FR.pdf\" target=\"_blank\" rel=\"noopener\">15\/01\/2020 \u2013 CROISSANCE SOUTENUE DE +27% DU CHIFFRE D\u2019AFFAIRES POUR L\u2019ANN\u00c9E 2019<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2019&Prime; tab_id=\u00a0\u00bblqd-1719483474781-a0c1e880-b975&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.12.10_DMS-CP_DMS-BIOTECH-Arthrose_FR.pdf\" target=\"_blank\" rel=\"noopener\">10\/12\/2019 \u2013 ESSAI CLINIQUE SUR L\u2019ARTHROSE : EFFICACIT\u00c9 DE L\u2019INJECTION INTRA-ARTICULAIRE DE CELLULES ADIPEUSES SUP\u00c9RIEURE \u00c0 L\u2019ACIDE HYALURONIQUE SUR L\u2019ENSEMBLE DES CINQ CRIT\u00c8RES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.12.09_DMS-CP_DMS-BIOTECH-H2020-SME-Phase1_FR.pdf\" target=\"_blank\" rel=\"noopener\">09\/12\/2019 \u2013 DMS BIOTECH (HYBRIGENICS) FINALISE LA PHASE 1 DE L\u2019APPEL \u00c0 PROJETS INSTRUMENT PME DU PROGRAMME EUROP\u00c9EN HORIZON 2020 DANS LE CADRE DE SES RECHERCHES SUR LE TRAITEMENT DES DYSFONCTIONS \u00c9RECTILES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.12.05_DMS_CP_FIN-CONTRAT-ORNANE_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">05\/12\/2019 \u2013 DMS GROUP ET EHGO METTENT FIN AU CONTRAT DE FINANCEMENT PAR \u00c9MISSION D\u2019ORNANE AVEC BSA ATTACH\u00c9S D\u2019UN MONTANT MAXIMUM DE 25 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.12.05_DMS_CP_EMISSION-OBLIGATIONS_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">05\/12\/2019 \u2013 MISE EN PLACE D\u2019UN FINANCEMENT D\u2019UN MONTANT MAXIMUM DE 4 M\u20ac PAR BONS D\u2019\u00c9MISSION D\u2019OBLIGATIONS REMBOURSABLES EN NUM\u00c9RAIRE ET\/OU EN ACTIONS DMS OU HYBRIGENICS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.12.02_DMS_CP_FUJIFILM-RADIOLOGIE_FR.pdf\" target=\"_blank\" rel=\"noopener\">03\/12\/2019 \u2013 DMS GROUP ET FUJIFILM EUROPE ANNONCENT UN NOUVEL ACCORD POUR LA FABRICATION ET LA COMMERCIALISATION DE SOLUTIONS DE SALLES DE RADIOLOGIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.10.23_DMS_CP_CA-T3-2019_FR.pdf\" target=\"_blank\" rel=\"noopener\">23\/10\/2019 \u2013 CROISSANCE DE +27% DU CHIFFRE D\u2019AFFAIRES \u00c0 FIN SEPTEMBRE 2019<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.10.16_DMS-CP_CERTIFICATION-FDA_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">16\/10\/2019 \u2013 HYBRIGENICS, DIVISION BIOTECH DE DMS GROUP, MET LE CAP SUR LES ETATS-UNIS !<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.10.15_DMS_CP_CLOSING_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">15\/10\/2019 \u2013 FINALISATION DE L\u2019APPORT PARTIEL D\u2019ACTIF DU P\u00d4LE DMS BIOTECH : DMS GROUP D\u00c9TIENT 80% DU CAPITAL D\u2019HYBRIGENICS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.10.09_DMS_CP_DEROGATION-AMF_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">09\/10\/2019 \u2013 PROJET DE PRISE DE CONTR\u00d4LE D\u2019HYBRIGENICS PAR VOIE D\u2019APPORT PARTIEL D\u2019ACTIF DU P\u00d4LE DMS BIOTECH : OBTENTION PAR DMS GROUP D\u2019UNE D\u00c9ROGATION DE L\u2019AMF \u00c0 L\u2019OBLIGATION DE D\u00c9POSER UNE OFFRE PUBLIQUE SUR LES TITRES HYBRIGENICS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.09.30_DMS_CP_RS-2019_FR_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2019 \u2013 R\u00c9SULTATS SEMESTRIELS 2019<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.09.17_DMS_CP_POST-AGM-16092019_FR.pdf\" target=\"_blank\" rel=\"noopener\">17\/09\/2019 \u2013 APPROBATION DES ACTIONNAIRES DE DMS SUR LE PROJET DE PRISE DE CONTR\u00d4LE D\u2019HYBRIGENICS PAR VOIE D\u2019APPORT PARTIEL D\u2019ACTIF DU P\u00d4LE DMS BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.09.12_DMS_CP_FR.pdf\" target=\"_blank\" rel=\"noopener\">12\/09\/2019 \u2013 FORUM BOURSORAMA : CONDAMNATION D\u00c9FINITIVE DE M. ANTOINE RABASTE, ANCIEN PDG, POUR DIFFAMATION<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.08.13_DMS_CP_MAD-DOCS-AGM-03092019_-VDF.pdf\" target=\"_blank\" rel=\"noopener\">13\/08\/2019 \u2013 MISE \u00c0 DISPOSITION DES DOCUMENTS PR\u00c9PARATOIRES \u00c0 L\u2019ASSEMBLE G\u00c9N\u00c9RALE MIXTE DU 3 SEPTEMBRE 2019<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.08.01_DMS_CP_MAD-RFA-2018_VDF.pdf\" target=\"_blank\" rel=\"noopener\">01\/08\/2019 \u2013 MISE \u00c0 DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.07.29_DMS_CP_AGM-03092019_FR.pdf\" target=\"_blank\" rel=\"noopener\">29\/07\/2019 \u2013 CONVOCATION DES ACTIONNAIRES \u00c0 UNE ASSEMBL\u00c9E G\u00c9N\u00c9RALE MIXTE LE 3 SEPTEMBRE 2019 EN VUE NOTAMMENT D\u2019APPROUVER LE PROJET DE PRISE DE CONTR\u00d4LE D\u2019HYBRIGENICS PAR VOIE D\u2019APPORT PARTIEL D\u2019ACTIF DU P\u00d4LE DMS BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.07.22_DMS_CP_CA-S1-2019_FR.pdf\" target=\"_blank\" rel=\"noopener\">22\/07\/2019 \u2013 CROISSANCE DE +31% DU CHIFFRE D\u2019AFFAIRES AU 1ER SEMESTRE 2019<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.06.20_DMS_CP_POINT-ETAPE-HYBRIGENICS_FR.pdf\" target=\"_blank\" rel=\"noopener\">20\/06\/2019 \u2013 POINT D\u2019\u00c9TAPE SUR LE PROJET DE PRISE DE CONTR\u00d4LE D\u2019HYBRIGENICS PAR VOIE D\u2019APPORT PARTIEL D\u2019ACTIF PAR DMS GROUP DE SON P\u00d4LE DMS BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.06.12_DMS_CP_DMS-BIOTECH-DEVELOPPEMENTS-ARTHROSE_VDF.pdf\" target=\"_blank\" rel=\"noopener\">12\/06\/2019 \u2013 LE PROJET ARTHROSE DE DMS BIOTECH : UNE R\u00c9PONSE SIMPLE, PEU CO\u00dbTEUSE ET EFFICACE \u00c0 UN BESOIN M\u00c9DICAL NON SATISFAIT<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.06.03_DMS_CP_EXTENSION-FUJIFILM-EUROPE_FR.pdf\" target=\"_blank\" rel=\"noopener\">03\/06\/2019 \u2013 EXTENSION DES ACCORDS COMMERCIAUX ET INDUSTRIELS AVEC FUJIFILM EUROPE AU MOYEN-ORIENT, EN AFRIQUE ET EN ASIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.05.22_DMScpRESULTATSARTHROSE.pdf\" target=\"_blank\" rel=\"noopener\">22\/05\/2019 \u2013 R\u00c9SULTATS POSITIFS DE L\u2019ESSAI CLINIQUE SUR L\u2019ARTHROSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.04.29_DMS_CP_RA-2018_FR.pdf\" target=\"_blank\" rel=\"noopener\">29\/04\/2019 \u2013 R\u00c9SULTATS ANNUELS 2018<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.04.25_DMS_CP_DEVELOPPEMENTS-DMS-BIOTECH_FR.pdf\" target=\"_blank\" rel=\"noopener\">25\/04\/2019 \u2013 NOUVELLES AVANC\u00c9ES POUR LA DIVISION DMS BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.02.28_DMS_CP_CA-2018_FR_VDF-1.pdf\" target=\"_blank\" rel=\"noopener\">28\/02\/2019 \u2013 24,3 M\u20ac DE CHIFFRE D\u2019AFFAIRES EN 2018<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.02.07_DMS_HYBRIGENICS_CP_NEGOCIATION-EXCLUSIVE-FR.pdf\" target=\"_blank\" rel=\"noopener\">07\/02\/2019 \u2013 DMS GROUP ET HYBRIGENICS ENTRENT EN N\u00c9GOCIATION EXCLUSIVE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.01.17_DMS_CP_H2020_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">17\/01\/2019 \u2013 DMS BIOTECH PASSE AVEC SUCC\u00c8S LA PHASE 1 DE L\u2019APPEL \u00c0 PROJETS INSTRUMENT P.M.E DU PROGRAMME EUROP\u00c9EN HORIZON 2020 DANS LE CADRE DE SES RECHERCHES SUR LE TRAITEMENT DES DYSFONCTIONS \u00c9RECTILES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.01.11_DMS_CP_ARTHROSE_VF.pdf\" target=\"_blank\" rel=\"noopener\">11\/01\/2019 \u2013 PREMIERS R\u00c9SULTATS ENCOURAGEANTS DE L\u2019ESSAI CLINIQUE SUR L\u2019ARTHROSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2019.01.09_DMS_CP_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">09\/01\/2019 \u2013 LIVRAISON DE LA FUTURE UNIT\u00c9 DE PRODUCTION DE DMS GROUP AU 2\u00c8ME TRIMESTRE 2020<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2018&Prime; tab_id=\u00a0\u00bblqd-1719483482943-c448c869-363b\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.11.15_DMS_CP_CA-T3-2018_VF.pdf\" target=\"_blank\" rel=\"noopener\">15\/11\/2018 \u2013 16,9 M\u20ac DE CHIFFRE D\u2019AFFAIRES \u00c0 NEUF MOIS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.10.12_DMS_CP_UGAP_FR.pdf\" target=\"_blank\" rel=\"noopener\">12\/10\/2018 \u2013 LES SOLUTIONS D\u2019IMAGERIE DMS IMAGING S\u00c9LECTIONN\u00c9ES PAR L\u2019UGAP, LA CENTRALE D\u2019ACHAT PUBLIC G\u00c9N\u00c9RALISTE EN FRANCE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.09.28_DMS_CP_RS-2018_FR.pdf\" target=\"_blank\" rel=\"noopener\">28\/09\/2018 \u2013 R\u00c9SULTATS SEMESTRIELS 2018<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.09.24_DMS-Intrasense_CP_commun_Fin-negociations-exclusives.pdf\" target=\"_blank\" rel=\"noopener\">24\/09\/2018 \u2013 INTRASENSE ET DMS GROUP METTENT FIN \u00c0 LEURS N\u00c9GOCIATIONS EXCLUSIVES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.08.28_DMS_CP_CA-S1-2018_FR.pdf\" target=\"_blank\" rel=\"noopener\">28\/08\/2018 \u2013 CHIFFRE D\u2019AFFAIRES DU 1ER SEMESTRE 2018 : 10,7 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.06.08_DMS_CP_REPORT-AG_VF.pdf\" target=\"_blank\" rel=\"noopener\">08\/06\/2018 \u2013 REPORT DE L\u2019ASSEMBL\u00c9E G\u00c9N\u00c9RALE ANNUELLE DES ACTIONNAIRES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.05.22_DMS_CP_AVANCEE-BMS-BIOTECH_VDEF_FR.pdf\" target=\"_blank\" rel=\"noopener\">22\/05\/2018 \u2013 NOUVELLE AVANC\u00c9E POUR LA DIVISION DMS BIOTECH : FINALISATION D\u2019UNE \u00c9TUDE PR\u00c9CLINIQUE SUR LE TRAITEMENT DES DYSFONCTIONS \u00c9RECTILES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.05.15_DMS-Intrasense_CP_Negociations-exclusives_FR.pdf\" target=\"_blank\" rel=\"noopener\">15\/05\/2018 \u2013 INTRASENSE ET DMS GROUP ENTRENT EN N\u00c9GOCIATION EXCLUSIVE EN VUE DE L\u2019APPORT DES ACTIVIT\u00c9S D\u2019IMAGERIE M\u00c9DICALE DE DMS GROUP \u00c0 LA SOCI\u00c9T\u00c9 INTRASENSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.05.15_DMS_CP_Financement-ORNANE_VF.pdf\" target=\"_blank\" rel=\"noopener\">15\/05\/2018 \u2013 MISE EN PLACE D\u2019UN FINANCEMENT PAR \u00c9MISSION D\u2019ORNANE AVEC BSA ATTACH\u00c9S D\u2019UN MONTANT NOMINAL MAXIMUM DE 25 M\u20ac SUR 5 ANS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.05.15_DMS_CP_CA-T1-2018_VF.pdf\" target=\"_blank\" rel=\"noopener\">15\/05\/2018 \u2013 CHIFFRE D\u2019AFFAIRES DU 1ER TRIMESTRE 2018 : 4,9 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.04.30_DMS_CP_RA-2017_VF.pdf\" target=\"_blank\" rel=\"noopener\">30\/04\/2018 \u2013 R\u00c9SULTATS ANNUELS 2017<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.04.26_DMS_CP_CELISS-RITSUBI_VF.pdf\" target=\"_blank\" rel=\"noopener\">26\/04\/2018 \u2013 ACCORD DE DISTRIBUTION AU JAPON DE LA SOLUTION CELLISS AVEC LA SOCI\u00c9T\u00c9 RITSUBI<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.04.17_DMS_CP_STEMCIS_VDF.pdf\" target=\"_blank\" rel=\"noopener\">17\/04\/2018 \u2013 NOMBREUSES AVANC\u00c9ES POUR LA DIVISION DMS BIOTECH<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.04.16_DMS_CP_CELLISS-JCCO_VF.pdf\" target=\"_blank\" rel=\"noopener\">16\/04\/2018 \u2013 SIGNATURE D\u2019UN CONTRAT DE DISTRIBUTION DE LA SOLUTION CELLISS EN CHINE AVEC LA SOCI\u00c9T\u00c9 JCCO<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.02.22_DMS_CP_UNIHA_VF.pdf\" target=\"_blank\" rel=\"noopener\">22\/02\/2018 \u2013 LES SOLUTIONS DE RADIOLOGIE DE DMS GROUP R\u00c9F\u00c9RENC\u00c9ES PAR UNIHA<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2018.02.02_DMS_CP_CA-2017_VF.pdf\" target=\"_blank\" rel=\"noopener\">02\/02\/2018 \u2013 CHIFFRE D\u2019AFFAIRES ANNUEL DE 27,1 M\u20ac EN 2017<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2017&Prime; tab_id=\u00a0\u00bblqd-1719483493902-99a712e0-652d\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.12.07_DMS_CP_POINT-ETAPE-UNITE_VF.pdf\" target=\"_blank\" rel=\"noopener\">07\/12\/2017 \u2013 POINT D\u2019\u00c9TAPE SUR LE PROJET DE FUTURE UNIT\u00c9 DE PRODUCTION VISANT \u00c0 DOUBLER LES CAPACIT\u00c9S INDUSTRIELLES DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.10.27_DMS_CP_CA-9M-2017_VF.pdf\" target=\"_blank\" rel=\"noopener\">27\/10\/2017 \u2013 CHIFFRE D\u2019AFFAIRES \u00c0 NEUF MOIS DE 19,3 M\u20ac, AVEC UNE CROISSANCE DE +8% DE L\u2019ACTIVIT\u00c9 DE RADIOLOGIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.09.29_DMS_CP_RS-2017_VF.pdf\" target=\"_blank\" rel=\"noopener\">29\/09\/2017 \u2013 R\u00c9SULTATS SEMESTRIELS 2017<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.09.18_DMS_CP_ADIPSCULPT-ASIE_VFF.pdf\" target=\"_blank\" rel=\"noopener\">18\/09\/2017 \u2013 DMS BIOTECH POURSUIT SON D\u00c9VELOPPEMENT EN ASIE AVEC LA SIGNATURE EN CHINE D\u2019UN NOUVEL ACCORD POUR SES SOLUTIONS DE LIPOFILLING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.07.25_DMS_CP_CA-S1-2017_VFF.pdf\" target=\"_blank\" rel=\"noopener\">25\/07\/2017 \u2013 CHIFFRE D\u2019AFFAIRES SEMESTRIEL DE 12,7 M\u20ac, MARQU\u00c9 PAR LE DYNAMISME DE L\u2019ACTIVIT\u00c9 RADIOLOGIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.06.26_DMS_CP_FINALISATION-CESSION-ALPHA-MOS_VF.pdf\" target=\"_blank\" rel=\"noopener\">26\/06\/2017 \u2013 FINALISATION DE LA CESSION DE LA PARTICIPATION D\u00c9TENUE DANS ALPHA MOS POUR UN MONTANT 6,5 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.06.23_DMS_CP_PROJET-CESSION-ALPHA-MOS_VF.pdf\" target=\"_blank\" rel=\"noopener\">23\/06\/2017 \u2013 N\u00c9GOCIATIONS EXCLUSIVES EN VUE DE LA CESSION DE LA PARTICIPATION D\u00c9TENUE DANS ALPHA MOS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.05.12_DMS_CP_CA-T1-2017_VF.pdf\" target=\"_blank\" rel=\"noopener\">12\/05\/2017 \u2013 BON D\u00c9BUT D\u2019EXERCICE 2017 : CHIFFRE D\u2019AFFAIRES DU 1ER TRIMESTRE EN PROGRESSION DE +9% \u00c0 P\u00c9RIM\u00c8TRE COMPARABLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.05.09_DMS_CP_ADISCULPT-THAILANDE_VF.pdf\" target=\"_blank\" rel=\"noopener\">09\/05\/2017 \u2013 DMS BIOTECH SIGNE UN NOUVEL ACCORD DE DISTRIBUTION EN THA\u00cfLANDE POUR SES SOLUTIONS DE LIPOFILLING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.05.02_DMS_CP_PRECISION-NOMBRE-ACTIONS_VF.pdf\" target=\"_blank\" rel=\"noopener\">02\/05\/2017 \u2013 PR\u00c9CISION SUR LE NOMBRE D\u2019ACTIONS COMPOSANT LE CAPITAL SOCIAL DE DMS GROUP<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.04.28_DMS_CP_RA-2016_VF.pdf\" target=\"_blank\" rel=\"noopener\">28\/04\/2017 \u2013 R\u00c9SULTATS ANNUELS 2016<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.03.02_DMS_CP_FUJI_VF.pdf\" target=\"_blank\" rel=\"noopener\">02\/03\/2017 \u2013 DMS GROUP ET FUJIFILM EUROPE CONCLUENT DEUX ACCORDS COMMERCIAUX ET INDUSTRIELS EN IMAGERIE M\u00c9DICALE ET OST\u00c9ODENSITOM\u00c9TRIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.02.10_DMS_CP_CA-2016_VDEF.pdf\" target=\"_blank\" rel=\"noopener\">10\/02\/2017 \u2013 CHIFFRE D\u2019AFFAIRES 2016 : 37,4 M\u20ac EN PROGRESSION DE +3%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2017.01.11_DMS_CP_ACCORD-NGI_11012017_VF.pdf\" target=\"_blank\" rel=\"noopener\">11\/01\/2017 \u2013 SIGNATURE D\u2019UN ACCORD STRAT\u00c9GIQUE ENTRE DMS ET LE GROUPE NGI, 1ER ACTEUR FRAN\u00c7AIS D\u00c9DI\u00c9 \u00c0 L\u2019ACCOMPAGNEMENT DES CENTRES D\u2019IMAGERIE<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2016&Prime; tab_id=\u00a0\u00bblqd-1719483503128-15fc2e2c-21ec\u00a0\u00bb][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.12.14_Communique-DMS-Wellness-signe-un-accord-de-distribution-au-Japon-pour-sa-solution-de-lipofilling.pdf\" target=\"_blank\" rel=\"noopener\">14\/12\/2016 \u2013 DMS WELLNESS SIGNE UN ACCORD DE DISTRIBUTION AU JAPON POUR SA SOLUTION DE LIPOFILLING<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.11.16_DMS_CP_DMS-DIVISIONS_VF.pdf\" target=\"_blank\" rel=\"noopener\">16\/11\/2016 \u2013 DMS GROUP D\u00c9VOILE SA NOUVELLE IDENTIT\u00c9 VISUELLE ET L\u2019ORGANISATION DE SES ACTIVIT\u00c9S<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.11.15_Communique-Chiffre-daffaires-fin-septembre-2016-259ME-1.pdf\" target=\"_blank\" rel=\"noopener\">15\/11\/2016 \u2013 CHIFFRE D\u2019AFFAIRES \u00c0 FIN SEPTEMBRE 2016 : 25,9 M\u20ac EN PROGRESSION DE +5% SUR NEUF MOIS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.10.10_Communique-DMS-conclut-un-accord-industriel-avec-Canon.pdf\" target=\"_blank\" rel=\"noopener\">10\/10\/2016 \u2013 DMS CONCLUT UN ACCORD INDUSTRIEL AVEC CANON POUR L\u2019INTEGRATION DE SON DETECTEUR DYNAMIQUE SUR SES SOLUTIONS DE RADIOLOGIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.10.05_Communique-AXS-Medical-filiale-du-Groupe-DMS-renforce-sa-force-de-vente-commerciale.pdf\" target=\"_blank\" rel=\"noopener\">05\/10\/2016 \u2013 AXS MEDICAL, FILIALE DU GROUPE DMS, RENFORCE SA FORCE DE VENTE COMMERCIALE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.09.30_Communique-Resultats-semestriels-2016-Rentabilite-des-activites-de-DMS-Imaging-EBITDA-consolide-du-Groupe-positif-au-1er-semestr.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2016 \u2013 R\u00c9SULTATS SEMESTRIELS 2016 : RENTABILIT\u00c9 DES ACTIVIT\u00c9S DE DMS IMAGING EBITDA CONSOLID\u00c9 DU GROUPE POSITIF AU 1ER SEMESTRE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.09.02_Communique-Information-relative-au-nombre-de-droits-de-vote-et-dactions-composant-le-capital-au-31-aout-2016-1.pdf\" target=\"_blank\" rel=\"noopener\">02\/09\/2016 \u2013 INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D\u2019ACTIONS COMPOSANT LE CAPITAL AU 31 AOUT 2016<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.08.31_Communique-Forum-Boursorama-DMS-poursuivra-les-auteurs-des-messages-diffamatoires-ou-denigrants.pdf\" target=\"_blank\" rel=\"noopener\">31\/08\/2016 \u2013 FORUM BOURSORAMA : DMS POURSUIVRA LES AUTEURS DES MESSAGES DIFFAMATOIRES OU DENIGRANTS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.08.25_Communique-Chiffre-daffaires-du-1er-semestre-2016-170-ME-2.pdf\" target=\"_blank\" rel=\"noopener\">25\/08\/2016 \u2013 CHIFFRE D\u2019AFFAIRES DU 1ER SEMESTRE 2016 : 17,0 M\u20ac<\/a><\/li>\n<li style=\"text-align: left;\"><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.06.28_Communique-DMS-choisit-la-region-de-Nimes-pour-sa-future-unite-de-production-avec-pour-objectif-de-doubler-sa-capacite-in.pdf\" target=\"_blank\" rel=\"noopener\">28\/06\/2016 \u2013 DMS CHOISIT LA REGION DE N\u00ceMES POUR SA FUTURE UNITE DE PRODUCTION AVEC POUR OBJECTIF DE DOUBLER SA CAPACITE INDUSTRIELLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.06.17_Communique-Regroupement-des-actions-DMS-10-actions-anciennes-contre-1-nouvelle.pdf\" target=\"_blank\" rel=\"noopener\">17\/06\/2016 \u2013 REGROUPEMENT DES ACTIONS DMS : 10 ACTIONS ANCIENNES CONTRE 1 NOUVELLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.06.17_Communique-Les-radiologues-du-Groupe-Imagerie-Medicale-du-Biterrois-ont-choisi-les-solutions-dimagerie-de-DMS.pdf\" target=\"_blank\" rel=\"noopener\">17\/06\/2016 \u2013 LES RADIOLOGUES DU GROUPE IMAGERIE MEDICALE DU BITERROIS ONT CHOISI LES SOLUTIONS D\u2019IMAGERIE DMS<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.06.07_Communique-Projet-de-regroupement-des-titres-DMS-10-actions-anciennes-contre-1-nouvelle.pdf\" target=\"_blank\" rel=\"noopener\">07\/06\/2016 \u2013 PROJET DE REGROUPEMENT DES TITRES DMS : 10 ACTIONS ANCIENNES CONTRE 1 NOUVELLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.05.12_Communique-Forte-croissance-du-pole-radiologie-osteodensitometrie-21-progression-de-8-du-chiffre-daffaires-au-1er.pdf\" target=\"_blank\" rel=\"noopener\">12\/05\/2016 \u2013 FORTE CROISSANCE DU POLE RADIOLOGIE &amp; OSTEODENSITOMETRIE : +21% \u2013 PROGRESSION DE 8% DU CHIFFRE D\u2019AFFAIRES AU 1ER TRIMESTRE 2016<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.05.09_Communique-DMS-annonce-le-deploiement-de-sa-solution-BIOMOD-3S-au-sein-du-groupe-de-radiologie-lyonnais-Norimagerie.pdf\" target=\"_blank\" rel=\"noopener\">09\/05\/2016 \u2013 DMS ANNONCE LE DEPLOIEMENT DE SA SOLUTION BIOMOD 3S AU SEIN DU GROUPE DE RADIOLOGIE LYONNAIS NORIMAGERIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.04.29_Communique-Resultats-annuels-2015-EBITA-positif-de-09-ME-sur-le-perimetre-historique-Objectif-de-croissance-soutenue-su.pdf\" target=\"_blank\" rel=\"noopener\">29\/04\/2016 \u2013 RESULTATS ANNUELS 2015 : EBITDA POSITIF DE 0,9 M\u20ac SUR LE PERIMETRE HISTORIQUE \u2013 OBJECTIF DE CROISSANCE SOUTENUE SUR LE PERIMETRE HISTORIQUE EN 2016<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.03.23_Communique-Modification-temporaire-des-caracteristiques-des-BSA2017.pdf\" target=\"_blank\" rel=\"noopener\">23\/03\/2016 \u2013\u00a0 MODIFICATION TEMPORAIRE DES CARACTERISTIQUES DES BSA2017<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.03.09_Communique-STEMCIS-lance-une-etude-clinique-chez-lhomme-pour-son-dispositif-medical-de-traitement-de-larthrose-base-sur.pdf\" target=\"_blank\" rel=\"noopener\">09\/03\/2016 \u2013 STEMCIS LANCE UNE ETUDE CLINIQUE CHEZ L\u2019HOMME POUR SON DISPOSITIF MEDICAL DE TRAITEMENT DE L\u2019ARTHROSE BASE SUR LES CELLULES SOUCHES ADIPEUSES<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.03.07_Communique-Signature-dun-contrat-de-19ME-en-radiologie-en-afrique-de-louest.pdf\" target=\"_blank\" rel=\"noopener\">07\/03\/2016 \u2013 SIGNATURE D\u2019UN CONTRAT DE 1,9 M\u20ac EN RADIOLOGIE EN AFRIQUE DE L\u2019OUEST<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.03.02_Communique-La-technologie-BIOMOD\u21223S-adoptee-par-Toshiba-Medical-Systems-Europe.pdf\" target=\"_blank\" rel=\"noopener\">02\/03\/2016 \u2013 LA TECHNOLOGIE BIOMOD\u2122 3S ADOPTEE PAR TOSHIBA MEDICAL SYSTEMS EUROPE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.02.11_Communique-Chiffre-daffaires-annuel-2015-364-ME-en-progression-de-48-dont-20-a-perimetre-comparable.pdf\" target=\"_blank\" rel=\"noopener\">11\/02\/2016 \u2013 CHIFFRE D\u2019AFFAIRES ANNUEL 2015 : 36,4 M\u20ac EN PROGRESSION DE +48% DONT +20% A PERIMETRE COMPARABLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2016.01.20_Communique-Projet-de-modification-des-caracteristiques-des-BSA2017.pdf\" target=\"_blank\" rel=\"noopener\">20\/01\/2016 \u2013 PROJET DE MODIFICATION DES CARACTERISTIQUES DES BSA2017 : REDUCTION DU PRIX D\u2019EXERCICE DE 0,20 \u20ac A 0,18 \u20ac PENDANT UNE DUREE DE 20 JOURS OUVRES MAXIMUM<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=\u00a0\u00bb2015&Prime; tab_id=\u00a0\u00bblqd-1719483512756-069d6cc4-aed1&Prime;][vc_column_text]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.11.20_Communique-Finalisation-de-lacquisition-de-STEMCIS-Biotech-innovante-specialisee-dans-les-solutions-medicales-utilisant-le-tissu-adipeux.pdf\" target=\"_blank\" rel=\"noopener\">20\/11\/2015 \u2013 FINALISATION DE L\u2019ACQUISITION DE STEMCIS, BIOTECH INNOVANTE SPECIALISEE DANS LES SOLUTIONS MEDICALES UTILISANT LE TISSU ADIPEUX<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.11.13_Communique-Cession-par-DMS-de-10-du-capital-dAlpha-M.O.S-a-son-president-directeur-general.pdf\" target=\"_blank\" rel=\"noopener\">13\/11\/2015 \u2013 CESSION PAR DMS DE 10% DU CAPITAL D\u2019ALPHA M.O.S A SON PRESIDENT DIRECTEUR GENERAL<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.10.22_Communique-Croissance-organique-de-54-au-3eme-trimestre-2015-de-lactivite-radiologie-osteodensitometrie-Chiffre-daffaires-du-Groupe-a-neuf-mois-de-247-ME-en-hausse-de-80.pdf\" target=\"_blank\" rel=\"noopener\">22\/10\/2015 \u2013 CROISSANCE ORGANIQUE DE 54% AU 3EME TRIMESTRE 2015 DE L\u2019ACTIVITE RADIOLOGIE-OSTEODENSITOMETRIE \u2013 CHIFFRE D\u2019AFFAIRES DU GROUPE A NEUF MOIS DE 24,7 M\u20ac EN HAUSSE DE 80%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.09.30_Communique-Resultats-Semestriels-2015.pdf\" target=\"_blank\" rel=\"noopener\">30\/09\/2015 \u2013 RESULTATS SEMESTRIELS 2015<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.08.03_Communique-ACQUISITION-DE-STEMCIS-MEDTECH-BIOTECH-INNOVANTE-SPECIALISEE-DANS-LES-SOLUTIONS-MEDICALES-UTILISANT-LE-TISSU-ADIPEUX.pdf\" target=\"_blank\" rel=\"noopener\">03\/08\/2015 \u2013 ACQUISITION DE STEMCIS, MEDTECH &amp; BIOTECH INNOVANTE SPECIALISEE DANS LES SOLUTIONS MEDICALES UTILISANT LE TISSU ADIPEUX \u2013 UN FORT POTENTIEL DE DEVELOPPEMENT SUR LE MARCHE DU TRAITEMENT DE L\u2019ARTHROSE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.07.23_Communique-Forte-acceleration-de-la-croissance-au-2eme-trimestre-71-dont-41-a-perimetre-comparable.pdf\" target=\"_blank\" rel=\"noopener\">23\/07\/2015 \u2013 FORTE ACCELERATION DE LA CROISSANCE AU 2EME TRIMESTRE : +71% DONT +41% A PERIMETRE COMPARABLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.07.08_Communique-DMS-acquiert-AXS-Medical-specialiste-de-limagerie-stereo-radiographie-et-de-la-modelisation-3D-appliquee-a-lorthopedie.pdf\" target=\"_blank\" rel=\"noopener\">08\/07\/2015 \u2013 DMS ACQUIERT AXS MEDICAL, SPECIALISTE DE L\u2019IMAGERIE STEREORADIOGRAPHIQUE ET DE LA MODELISATION 3D APPLIQUEE A L\u2019ORTHOPEDIE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.05.19_Communique-Premiere-livraison-dune-table-Platinum-aux-Etats-Unis-Poursuite-du-developpement-commercial-en-Chine.pdf\" target=\"_blank\" rel=\"noopener\">19\/05\/2015 \u2013 PREMIERE LIVRAISON D\u2019UNE TABLE PLATINUM AUX ETATS-UNIS POURSUITE DU DEVELOPPEMENT COMMERCIAL EN CHINE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.05.11_Communique-Bon-debut-dexercice-2015-Chiffre-daffaires-du-1er-trimestre-en-hausse-de-66-dont-9-a-perimetre-comparable.pdf\" target=\"_blank\" rel=\"noopener\">11\/05\/2015 \u2013 BON DEBUT D\u2019EXERCICE 2015 : CHIFFRE D\u2019AFFAIRES DU 1ER TRIMESTRE EN HAUSSE DE +66%, DONT +9% A PERIMETRE COMPARABLE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.04.28_Communique-1ere-commande-par-Toshiba-Systems-Europe-dune-salle-de-radiologie-telecommandee-a-capteur-plan-dynamique.pdf\" target=\"_blank\" rel=\"noopener\">28\/04\/2015 \u2013 1ERE COMMANDE PAR TOSHIBA MEDICAL SYSTEMS EUROPE D\u2019UNE SALLE DE RADIOLOGIE TELECOMMANDEE A CAPTEUR PLAN DYNAMIQUE<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.04.20_Communique-DMS-realise-une-augmentation-de-capital-par-placement-prive-de-23-ME.pdf\" target=\"_blank\" rel=\"noopener\">20\/04\/2015 \u2013 DMS REALISE UNE AUGMENTATION DE CAPITAL PAR PLACEMENT PRIVE DE 2,3 M\u20ac<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.03.31_Communique-Resultats-Annuels-2014.pdf\" target=\"_blank\" rel=\"noopener\">31\/03\/2015 \u2013 RESULTATS ANNUELS 2014<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.03.02_Communique-DMS-et-Toshiba-annoncent-la-signature-dun-accord-commercial-Europeen.pdf\" target=\"_blank\" rel=\"noopener\">02\/03\/2015 \u2013 DMS ET TOSHIBA ANNONCENT LA SIGNATURE D\u2019UN ACCORD COMMERCIAL EUROPEEN<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.02.12_Communique-Chiffre-daffaires-2014-246-ME-en-progression-de-11.pdf\" target=\"_blank\" rel=\"noopener\">12\/02\/2015 \u2013 CHIFFRE D\u2019AFFAIRES 2014 : 24,6 M\u20ac EN PROGRESSION DE 11%<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.01.19_Communique-Agenda-Financier-2015.pdf\" target=\"_blank\" rel=\"noopener\">19\/01\/2015 &#8211; AGENDA FINANCIER 2015<\/a><\/li>\n<li><a href=\"https:\/\/www.dms-imaging.com\/wp-content\/uploads\/2024\/06\/2015.01.14_CP-DMS-obtient-lhomologation-des-autorites-chinoises-pour-la-commercialisation-de-sa-table-Platinum.pdf\" target=\"_blank\" rel=\"noopener\">14\/01\/2015 \u2013 DMS OBTIENT L\u2019HOMOLOGATION DES AUTORITES CHINOISES POUR LA COMMERCIALISATION DE SA TABLE PLATINUM<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row][vc_row][vc_column][ld_spacer height=\u00a0\u00bb100px\u00a0\u00bb][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][ld_fancy_heading tag=\u00a0\u00bbh2&Prime; alignment=\u00a0\u00bbtext-left\u00a0\u00bb]Communiqu\u00e9s de presse[\/ld_fancy_heading][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_accordion size=\u00a0\u00bbmd\u00a0\u00bb borders=\u00a0\u00bbaccordion-title-bordered\u00a0\u00bb items_shadow=\u00a0\u00bbyes\u00a0\u00bb heading_shadow=\u00a0\u00bbyes\u00a0\u00bb show_icon=\u00a0\u00bbyes\u00a0\u00bb i_add_icon=\u00a0\u00bbtrue\u00a0\u00bb expander_size=\u00a0\u00bbaccordion-expander-lg\u00a0\u00bb i_type=\u00a0\u00bblinea\u00a0\u00bb active_add_icon=\u00a0\u00bbtrue\u00a0\u00bb active_type=\u00a0\u00bblinea\u00a0\u00bb use_custom_fonts_title=\u00a0\u00bbtrue\u00a0\u00bb i_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-add\u00a0\u00bb active_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-remove\u00a0\u00bb fs=\u00a0\u00bb18px\u00a0\u00bb border_color=\u00a0\u00bbrgb(240, 242, 250)\u00a0\u00bb exp_color=\u00a0\u00bbrgb(0, 109, 255)\u00a0\u00bb bottom_margin=\u00a0\u00bb15px\u00a0\u00bb heading_color=\u00a0\u00bbrgb(0, 35, 82)\u00a0\u00bb fw=\u00a0\u00bb600&Prime; active_bg_color=\u00a0\u00bbrgb(0, 77, 182)\u00a0\u00bb active_exp_color=\u00a0\u00bbrgb(255, 255, 255)\u00a0\u00bb][vc_accordion_tab title=\u00a0\u00bb2026&Prime; tab_id=\u00a0\u00bbld-1573557703923-2b536dc1-8433&Prime;][vc_column_text] 14\/04\/2026 &#8211; Nouvelle forte progression des r\u00e9sultats annuels sur l\u2019exercice 2025 13\/04\/2026 &#8211; [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9140","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Communiqu\u00e9s de presse &#8212; DMS Imaging<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9s de presse &#8212; DMS Imaging\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][ld_fancy_heading tag=\u00a0\u00bbh2&Prime; alignment=\u00a0\u00bbtext-left\u00a0\u00bb]Communiqu\u00e9s de presse[\/ld_fancy_heading][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_accordion size=\u00a0\u00bbmd\u00a0\u00bb borders=\u00a0\u00bbaccordion-title-bordered\u00a0\u00bb items_shadow=\u00a0\u00bbyes\u00a0\u00bb heading_shadow=\u00a0\u00bbyes\u00a0\u00bb show_icon=\u00a0\u00bbyes\u00a0\u00bb i_add_icon=\u00a0\u00bbtrue\u00a0\u00bb expander_size=\u00a0\u00bbaccordion-expander-lg\u00a0\u00bb i_type=\u00a0\u00bblinea\u00a0\u00bb active_add_icon=\u00a0\u00bbtrue\u00a0\u00bb active_type=\u00a0\u00bblinea\u00a0\u00bb use_custom_fonts_title=\u00a0\u00bbtrue\u00a0\u00bb i_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-add\u00a0\u00bb active_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-remove\u00a0\u00bb fs=\u00a0\u00bb18px\u00a0\u00bb border_color=\u00a0\u00bbrgb(240, 242, 250)\u00a0\u00bb exp_color=\u00a0\u00bbrgb(0, 109, 255)\u00a0\u00bb bottom_margin=\u00a0\u00bb15px\u00a0\u00bb heading_color=\u00a0\u00bbrgb(0, 35, 82)\u00a0\u00bb fw=\u00a0\u00bb600&Prime; active_bg_color=\u00a0\u00bbrgb(0, 77, 182)\u00a0\u00bb active_exp_color=\u00a0\u00bbrgb(255, 255, 255)\u00a0\u00bb][vc_accordion_tab title=\u00a0\u00bb2026&Prime; tab_id=\u00a0\u00bbld-1573557703923-2b536dc1-8433&Prime;][vc_column_text] 14\/04\/2026 &#8211; Nouvelle forte progression des r\u00e9sultats annuels sur l\u2019exercice 2025 13\/04\/2026 &#8211; [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/\" \/>\n<meta property=\"og:site_name\" content=\"DMS Imaging\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T15:54:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/\",\"url\":\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/\",\"name\":\"Communiqu\u00e9s de presse &#8212; DMS Imaging\",\"isPartOf\":{\"@id\":\"https:\/\/www.dms-imaging.com\/#website\"},\"datePublished\":\"2024-06-27T12:49:28+00:00\",\"dateModified\":\"2026-04-14T15:54:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.dms-imaging.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9s de presse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.dms-imaging.com\/#website\",\"url\":\"https:\/\/www.dms-imaging.com\/\",\"name\":\"DMS Imaging\",\"description\":\"DMS Imaging is focused on the development, design and manufacturing of medical imaging systems mainly for digital radiology and bone densitometry.\",\"publisher\":{\"@id\":\"https:\/\/www.dms-imaging.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.dms-imaging.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.dms-imaging.com\/#organization\",\"name\":\"DMS Imaging\",\"url\":\"https:\/\/www.dms-imaging.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.dms-imaging.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dms-imaging.com\/wp-content\/uploads\/2023\/06\/imaging-blanc-MASK.png\",\"contentUrl\":\"https:\/\/dms-imaging.com\/wp-content\/uploads\/2023\/06\/imaging-blanc-MASK.png\",\"width\":2000,\"height\":578,\"caption\":\"DMS Imaging\"},\"image\":{\"@id\":\"https:\/\/www.dms-imaging.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/dmsimaging\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9s de presse &#8212; DMS Imaging","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9s de presse &#8212; DMS Imaging","og_description":"[vc_row][vc_column][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][ld_fancy_heading tag=\u00a0\u00bbh2&Prime; alignment=\u00a0\u00bbtext-left\u00a0\u00bb]Communiqu\u00e9s de presse[\/ld_fancy_heading][ld_spacer height=\u00a0\u00bb50px\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_accordion size=\u00a0\u00bbmd\u00a0\u00bb borders=\u00a0\u00bbaccordion-title-bordered\u00a0\u00bb items_shadow=\u00a0\u00bbyes\u00a0\u00bb heading_shadow=\u00a0\u00bbyes\u00a0\u00bb show_icon=\u00a0\u00bbyes\u00a0\u00bb i_add_icon=\u00a0\u00bbtrue\u00a0\u00bb expander_size=\u00a0\u00bbaccordion-expander-lg\u00a0\u00bb i_type=\u00a0\u00bblinea\u00a0\u00bb active_add_icon=\u00a0\u00bbtrue\u00a0\u00bb active_type=\u00a0\u00bblinea\u00a0\u00bb use_custom_fonts_title=\u00a0\u00bbtrue\u00a0\u00bb i_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-add\u00a0\u00bb active_icon_linea=\u00a0\u00bblqd-icn-ess icon-ion-ios-remove\u00a0\u00bb fs=\u00a0\u00bb18px\u00a0\u00bb border_color=\u00a0\u00bbrgb(240, 242, 250)\u00a0\u00bb exp_color=\u00a0\u00bbrgb(0, 109, 255)\u00a0\u00bb bottom_margin=\u00a0\u00bb15px\u00a0\u00bb heading_color=\u00a0\u00bbrgb(0, 35, 82)\u00a0\u00bb fw=\u00a0\u00bb600&Prime; active_bg_color=\u00a0\u00bbrgb(0, 77, 182)\u00a0\u00bb active_exp_color=\u00a0\u00bbrgb(255, 255, 255)\u00a0\u00bb][vc_accordion_tab title=\u00a0\u00bb2026&Prime; tab_id=\u00a0\u00bbld-1573557703923-2b536dc1-8433&Prime;][vc_column_text] 14\/04\/2026 &#8211; Nouvelle forte progression des r\u00e9sultats annuels sur l\u2019exercice 2025 13\/04\/2026 &#8211; [&hellip;]","og_url":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/","og_site_name":"DMS Imaging","article_modified_time":"2026-04-14T15:54:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/","url":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/","name":"Communiqu\u00e9s de presse &#8212; DMS Imaging","isPartOf":{"@id":"https:\/\/www.dms-imaging.com\/#website"},"datePublished":"2024-06-27T12:49:28+00:00","dateModified":"2026-04-14T15:54:20+00:00","breadcrumb":{"@id":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.dms-imaging.com\/fr\/communiques-de-presse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dms-imaging.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9s de presse"}]},{"@type":"WebSite","@id":"https:\/\/www.dms-imaging.com\/#website","url":"https:\/\/www.dms-imaging.com\/","name":"DMS Imaging","description":"DMS Imaging is focused on the development, design and manufacturing of medical imaging systems mainly for digital radiology and bone densitometry.","publisher":{"@id":"https:\/\/www.dms-imaging.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dms-imaging.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.dms-imaging.com\/#organization","name":"DMS Imaging","url":"https:\/\/www.dms-imaging.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.dms-imaging.com\/#\/schema\/logo\/image\/","url":"https:\/\/dms-imaging.com\/wp-content\/uploads\/2023\/06\/imaging-blanc-MASK.png","contentUrl":"https:\/\/dms-imaging.com\/wp-content\/uploads\/2023\/06\/imaging-blanc-MASK.png","width":2000,"height":578,"caption":"DMS Imaging"},"image":{"@id":"https:\/\/www.dms-imaging.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/dmsimaging\/"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/pages\/9140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/comments?post=9140"}],"version-history":[{"count":51,"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/pages\/9140\/revisions"}],"predecessor-version":[{"id":11802,"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/pages\/9140\/revisions\/11802"}],"wp:attachment":[{"href":"https:\/\/www.dms-imaging.com\/fr\/wp-json\/wp\/v2\/media?parent=9140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}